Brook StarRay Wireless Controller Now Available — Native PS5 Support Meets Xbox-Style Control 
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight 
Scalare Launches EquityRoom, Adding a Subscription Revenue Stream to Its Founder Ecosystem 
Megaannum Capital and Zhongke Xianxing Venture Capital Enter into Strategic Partnership Impact Podcast with John Shegerian Features Jon Powell of Saleforce
LOS ANGELES–(BUSINESS WIRE)–#esg–Jon Powell, PhD, Sustainability Practice Global Lead for Salesforce, is a featured guest…
Nozomi Networks Helps Facilitate Security for Gerdau’s Industrial Environment
Process visibility, asset inventory, and scalable cloud-based security are essential to keep up with the…
NordLayer launches a new and one-of-the-kind Browser Extension
LONDON, May 24, 2023 (GLOBE NEWSWIRE) — The NordLayer team is happy to announce that…
Silver Hammer Announces Closing of Private Placement Pursuant to the Listed Issuer Exemption
Vancouver, British Columbia–(Newsfile Corp. – May 24, 2023) – Silver Hammer Mining Corp. (CSE: HAMR)…
TechTarget Named a Leader in B2B Intent Data Providers Report by Independent Research Firm
The Company received highest possible scores in 11 criteria, including Vision, Innovation, Uniqueness of proprietary…
KBRA Assigns Preliminary Ratings to Saluda Grade Alternative Mortgage Trust 2023-SEQ3 (GRADE 2023-SEQ3)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 6 classes of mortgage-backed notes from Saluda Grade…
ClosedLoop Recognized as Best Place to Work by Austin Business Journal
AUSTIN, Texas–(BUSINESS WIRE)–ClosedLoop, a leading healthcare AI platform serving health plans and hospital systems across…
Zebra Technologies to Present at the Bernstein 39th Annual Strategic Decisions Conference
LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Zebra Technologies Corporation (NASDAQ: ZBRA), a leading digital solution provider enabling businesses to…
vTv Therapeutics Announces Issuance of U.S. Patent for Azeliragon as a Treatment of Glioblastoma to Cantex Pharmaceuticals
vTv discovered small molecule RAGE inhibitor being developed by Cantex under worldwide development and commercialization…
vTv Therapeutics Announces Issuance of U.S. Patent for Azeliragon as a Treatment of Glioblastoma to Cantex Pharmaceuticals
vTv discovered small molecule RAGE inhibitor being developed by Cantex under worldwide development and commercialization…
INmune Bio Inc.’s Chief Scientific Officer, Mark Lowdell, Ph.D. to Present Plenary Talk at International Society of Cell & Gene Therapy
Presidential Plenary Lecture to be Presented Wednesday, May 31 at the ICST Opening Session BOCA RATON, Fla.,…
INmune Bio Inc.’s Chief Scientific Officer, Mark Lowdell, Ph.D. to Present Plenary Talk at International Society of Cell & Gene Therapy
Presidential Plenary Lecture to be Presented Wednesday, May 31 at the ICST Opening Session BOCA RATON, Fla.,…
Aerami Therapeutics Announces Pharmacokinetic Data Demonstrating the Potential of AER-901 (Inhaled Imatinib) to Achieve Therapeutic Levels at Low Inhaled Doses for Treatment of Pulmonary Hypertension
DURHAM, N.C., May 24, 2023 (GLOBE NEWSWIRE) — Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical…
Aerami Therapeutics Announces Pharmacokinetic Data Demonstrating the Potential of AER-901 (Inhaled Imatinib) to Achieve Therapeutic Levels at Low Inhaled Doses for Treatment of Pulmonary Hypertension
DURHAM, N.C., May 24, 2023 (GLOBE NEWSWIRE) — Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical…
Palisade Bio’s LB1148 Two Ongoing Clinical Trials Expecting Topline Data Readouts
Company approaching Phase 2 topline data readout for prevention of post-surgical abdominal adhesions Continued momentum…
Palisade Bio’s LB1148 Two Ongoing Clinical Trials Expecting Topline Data Readouts
Company approaching Phase 2 topline data readout for prevention of post-surgical abdominal adhesions Continued momentum…
Biodexa Pharmaceuticals PLC Announces US$3.32 Million Registered Direct Offering
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN…
Biodexa Pharmaceuticals PLC Announces US$3.32 Million Registered Direct Offering
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN…
Ocugen, Inc. Announces Pricing of $16.5 Million Public Offering of Common Stock
MALVERN, Pa., May 24, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company…
Ocugen, Inc. Announces Pricing of $16.5 Million Public Offering of Common Stock
MALVERN, Pa., May 24, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company…